$15.43
0[0.00%]
At close: Apr 24
$15.43
0[0.00%]
PreMarket: 4:20PM EDT
Arcus Biosciences
(NYSE:RCUS)Latest News for Arcus Biosciences Stock (NYSE:RCUS)
Arcus Biosciences Stock (NYSE: RCUS)
Categories: All
Wednesday, April 24, 2024
Monday, March 25, 2024
Thursday, February 22, 2024
- Arcus Biosciences shares are trading higher after the company reported mixed Q4 financial results.Benzinga Newsdesk - Feb 22, 2024, 11:03AM
- Critical Insights From Arcus Biosciences Analyst Ratings: What You Need To KnowBenzinga Insights - Feb 22, 2024, 9:00AM
- Wedbush Reiterates Outperform on Arcus Biosciences, Maintains $30 Price TargetBenzinga Newsdesk - Feb 22, 2024, 8:23AM
Wednesday, February 21, 2024
Tuesday, February 20, 2024
Thursday, February 01, 2024
Tuesday, January 30, 2024
- Key Takeaways From Arcus Biosciences Analyst RatingsBenzinga Insights - Jan 30, 2024, 1:00PM
- Wedbush Maintains Outperform on Arcus Biosciences, Lowers Price Target to $30Benzinga Newsdesk - Jan 30, 2024, 10:46AM
- Mizuho Maintains Buy on Arcus Biosciences, Lowers Price Target to $42-Report Released on 29 January 2024Benzinga Newsdesk - Jan 30, 2024, 9:35AM
- Pharma Giant Gilead Raises Stake In Cancer-Focused Arcus Biosciences, Stock SoarsVandana Singh - Jan 30, 2024, 6:27AM
Wednesday, January 17, 2024
Tuesday, January 16, 2024
Monday, December 04, 2023
Monday, November 13, 2023
Wednesday, November 08, 2023
Tuesday, November 07, 2023
- Arcus Biosciences: Q3 Earnings InsightsBenzinga Insights - Nov 7, 2023, 4:21PM
- Arcus Biosciences Q3 2023 Gaap EPS $(0.94) Beats $(1.14) Estimate, Sales $32.00M Beat $27.28M EstimateBenzinga Newsdesk - Nov 7, 2023, 4:07PM
- Positive News For Gastric Cancers - Gilead/Arcus Biosciences' Combination Cancer Therapy Shows Encouraging Clinical ActivityVandana Singh - Nov 7, 2023, 11:17AM
- Earnings Scheduled For November 7, 2023Benzinga Insights - Nov 7, 2023, 6:34AM
Monday, November 06, 2023
Tuesday, October 17, 2023
Thursday, October 05, 2023
Tuesday, October 03, 2023
Tuesday, September 12, 2023
Thursday, September 07, 2023
Wednesday, September 06, 2023
Tuesday, September 05, 2023
Thursday, August 24, 2023
Wednesday, August 23, 2023
- Who Are Other Players Gaining From Roche's Accidental Lung Cancer Data UpdateVandana Singh - Aug 23, 2023, 3:05PM
- 12 Health Care Stocks Moving In Wednesday's Intraday SessionBenzinga Insights - Aug 23, 2023, 1:31PM
- Why Grab Holdings Are Trading Higher By 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day SessionLisa Levin - Aug 23, 2023, 1:02PM
- Arcus Biosciences shares are trading higher after Roche released the second interim analysis of Phase 3 study of tiragolumab, an anti-TIGIT therapy, for lung cancer. Note: Arcus is developing domvanalimab, also an anti-TIGIT antibody currently in multiple lung cancer studies.Benzinga Newsdesk - Aug 23, 2023, 12:24PM
- BTIG Reiterates Buy on Arcus Biosciences, Maintains $70 Price TargetBenzinga Newsdesk - Aug 23, 2023, 10:33AM
- Mizuho Reiterates Buy on Arcus Biosciences, Maintains $51 Price TargetBenzinga Newsdesk - Aug 23, 2023, 10:18AM
- 12 Health Care Stocks Moving In Wednesday's Pre-Market SessionBenzinga Insights - Aug 23, 2023, 9:06AM
- Why AMC Entertainment Shares Are Trading Lower By 21%; Here Are 20 Stocks Moving PremarketLisa Levin - Aug 23, 2023, 8:34AM
- Shares Of Arcus Biosciences Up 25% Premarket; Roche Earlier Reported Preliminary Results From Non-Small Cell Lung Cancer Study After Inadvertent Release Of DataCharles Gross - Aug 23, 2023, 6:19AM
- Urban Outfitters, Toll Brothers And Other Big Stocks Moving Higher In Wednesday's Pre-Market SessionLisa Levin - Aug 23, 2023, 6:10AM